S&P 500   3,092.62 (-0.05%)
DOW   27,757.65 (-0.09%)
QQQ   201.11 (-0.24%)
CGC   15.68 (-15.24%)
BABA   181.80 (-0.38%)
T   38.76 (-1.02%)
S&P 500   3,092.62 (-0.05%)
DOW   27,757.65 (-0.09%)
QQQ   201.11 (-0.24%)
CGC   15.68 (-15.24%)
BABA   181.80 (-0.38%)
T   38.76 (-1.02%)
S&P 500   3,092.62 (-0.05%)
DOW   27,757.65 (-0.09%)
QQQ   201.11 (-0.24%)
CGC   15.68 (-15.24%)
BABA   181.80 (-0.38%)
T   38.76 (-1.02%)
S&P 500   3,092.62 (-0.05%)
DOW   27,757.65 (-0.09%)
QQQ   201.11 (-0.24%)
CGC   15.68 (-15.24%)
BABA   181.80 (-0.38%)
T   38.76 (-1.02%)
Log in

Celgene SEC Filings & 10K Form (NASDAQ:CELG)

$109.84
-0.57 (-0.52 %)
(As of 11/14/2019 01:38 PM ET)
Today's Range
$109.53
Now: $109.84
$110.50
50-Day Range
$97.72
MA: $103.38
$110.61
52-Week Range
$58.59
Now: $109.84
$110.70
Volume204,080 shs
Average Volume4.25 million shs
Market Capitalization$78.17 billion
P/E Ratio14.43
Dividend YieldN/A
Beta1.41

SEC Filings

Celgene (NASDAQ:CELG) SEC Filings

DateFilerForm TypeView
11/06/2019
3:05 PM
Celgene (Issuer)
COX CARRIE SMITH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2019
3:05 PM
Biller Jonathan (Reporting)
Celgene (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2019
3:03 PM
Celgene (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2019
6:37 AM
Celgene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2019
3:05 PM
Celgene (Issuer)
Curran Terrie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2019
6:30 AM
Celgene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2019
3:10 PM
Celgene (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/30/2019
6:42 AM
Celgene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2019
3:00 PM
CASEY MICHAEL D (Reporting)
Celgene (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
3:00 PM
Celgene (Issuer)
MARIO ERNEST (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
3:00 PM
Celgene (Issuer)
Friedman Michael A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
3:00 PM
Celgene (Issuer)
LOUGHLIN JAMES J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
3:00 PM
BARKER RICHARD W (Reporting)
Celgene (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
3:00 PM
BONNEY MICHAEL W (Reporting)
Celgene (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
3:00 PM
Celgene (Issuer)
Haller Julia A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
3:05 PM
BARKER RICHARD W (Reporting)
Celgene (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
3:05 PM
Bishop Hans Edgar (Reporting)
Celgene (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
3:05 PM
BONNEY MICHAEL W (Reporting)
Celgene (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
3:05 PM
Celgene (Issuer)
COX CARRIE SMITH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
3:05 PM
Celgene (Issuer)
Friedman Michael A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
3:05 PM
Celgene (Issuer)
LOUGHLIN JAMES J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
3:05 PM
Celgene (Issuer)
WEILAND JOHN H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
3:05 PM
Celgene (Issuer)
MARIO ERNEST (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
3:05 PM
Celgene (Issuer)
Hall Patricia Hemingway (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
3:05 PM
Celgene (Issuer)
Haller Julia A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
3:05 PM
CASEY MICHAEL D (Reporting)
Celgene (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2019
3:30 PM
Celgene (Filed by)
IDEAYA Biosciences, Inc. (Subject)
Form SC 13G
05/06/2019
3:05 PM
AHMED NADIM (Reporting)
Celgene (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2019
3:05 PM
Biller Jonathan (Reporting)
Celgene (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/25/2019
4:09 PM
Celgene (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2019
3:53 PM
Celgene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2019
4:25 PM
BRISTOL MYERS SQUIBB CO (Filed by)
Celgene (Subject)
Form 425
04/12/2019
3:08 PM
Celgene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2019
3:06 PM
Celgene (Subject)
Form 425
04/04/2019
3:22 PM
BRISTOL MYERS SQUIBB CO (Filed by)
Celgene (Subject)
Form 425
04/04/2019
3:14 PM
Celgene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2019
3:12 PM
Celgene (Subject)
Form 425
03/29/2019
3:30 PM
BRISTOL MYERS SQUIBB CO (Filed by)
Celgene (Subject)
Form 425
03/29/2019
11:06 AM
Celgene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2019
4:01 PM
Celgene (Subject)
Form 425
03/26/2019
6:20 AM
Celgene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2019
6:18 AM
Celgene (Subject)
Form 425
03/26/2019
6:03 AM
BRISTOL MYERS SQUIBB CO (Filed by)
Celgene (Subject)
Form 425
03/25/2019
4:25 PM
BRISTOL MYERS SQUIBB CO (Filed by)
Celgene (Subject)
Form 425
03/19/2019
6:04 AM
BRISTOL MYERS SQUIBB CO (Filed by)
Celgene (Subject)
Form 425
03/19/2019
6:02 AM
BRISTOL MYERS SQUIBB CO (Filed by)
Celgene (Subject)
Form 425
03/18/2019
4:22 PM
BRISTOL MYERS SQUIBB CO (Filed by)
Celgene (Subject)
Form 425
03/15/2019
4:23 PM
BRISTOL MYERS SQUIBB CO (Filed by)
Celgene (Subject)
Form 425
03/13/2019
4:20 PM
BRISTOL MYERS SQUIBB CO (Filed by)
Celgene (Subject)
Form 425
03/12/2019
4:26 PM
BRISTOL MYERS SQUIBB CO (Filed by)
Celgene (Subject)
Form 425
03/12/2019
3:05 PM
Celgene (Subject)
Form 425
03/08/2019
4:20 PM
BRISTOL MYERS SQUIBB CO (Filed by)
Celgene (Subject)
Form 425
03/08/2019
4:01 PM
Celgene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2019
6:00 AM
BRISTOL MYERS SQUIBB CO (Filed by)
Celgene (Subject)
Form 425
03/07/2019
3:31 PM
BRISTOL MYERS SQUIBB CO (Filed by)
Celgene (Subject)
Form 425
03/07/2019
3:05 PM
Celgene (Issuer)
MARIO ERNEST (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2019
6:03 AM
BRISTOL MYERS SQUIBB CO (Filed by)
Celgene (Subject)
Form 425
03/06/2019
6:02 AM
BRISTOL MYERS SQUIBB CO (Filed by)
Celgene (Subject)
Form 425
03/06/2019
6:00 AM
BRISTOL MYERS SQUIBB CO (Filed by)
Celgene (Subject)
Form 425
03/05/2019
3:05 PM
Alles Mark J (Reporting)
Celgene (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
3:05 PM
Celgene (Issuer)
Elkins David V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
3:05 PM
Celgene (Issuer)
VESSEY RUPERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
3:05 PM
Celgene (Issuer)
REICIN ALISE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
3:05 PM
Biller Jonathan (Reporting)
Celgene (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
3:05 PM
AHMED NADIM (Reporting)
Celgene (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
3:05 PM
Celgene (Issuer)
Curran Terrie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
5:01 AM
BRISTOL MYERS SQUIBB CO (Filed by)
Celgene (Subject)
Form 425
03/01/2019
3:03 PM
Celgene (Filer)
Form 10-K/A
02/28/2019
3:30 PM
BRISTOL MYERS SQUIBB CO (Filed by)
Celgene (Subject)
Form 425
02/28/2019
5:08 AM
BRISTOL MYERS SQUIBB CO (Filed by)
Celgene (Subject)
Form 425
02/25/2019
6:16 AM
Celgene (Subject)
Form 425
02/22/2019
4:02 PM
BRISTOL MYERS SQUIBB CO (Filed by)
Celgene (Subject)
Form 425
02/22/2019
3:53 PM
BRISTOL MYERS SQUIBB CO (Filed by)
Celgene (Subject)
Form 425
02/22/2019
3:30 PM
Celgene (Filer)
Form DEFM14A
02/20/2019
4:00 PM
Celgene (Subject)
Form 425
02/20/2019
8:48 AM
BRISTOL MYERS SQUIBB CO (Filed by)
Celgene (Subject)
Form 425
02/20/2019
8:39 AM
BRISTOL MYERS SQUIBB CO (Filed by)
Celgene (Subject)
Form 425
02/20/2019
8:29 AM
BRISTOL MYERS SQUIBB CO (Filed by)
Celgene (Subject)
Form 425
02/19/2019
4:21 PM
BRISTOL MYERS SQUIBB CO (Filed by)
Celgene (Subject)
Form 425
02/15/2019
7:16 AM
BRISTOL MYERS SQUIBB CO (Filed by)
Celgene (Subject)
Form 425
02/11/2019
3:05 PM
Celgene (Issuer)
LOUGHLIN JAMES J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2019
10:16 AM
Celgene (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/05/2019
4:15 PM
Celgene (Subject)
Form 425
02/04/2019
9:07 AM
BlackRock Inc. (Filed by)
Celgene (Subject)
Form SC 13G/A
02/01/2019
3:27 PM
Celgene (Subject)
Form 425
01/31/2019
4:01 PM
Celgene (Subject)
Form 425
01/31/2019
6:34 AM
Celgene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/30/2019
4:07 PM
BRISTOL MYERS SQUIBB CO (Filed by)
Celgene (Subject)
Form 425
01/30/2019
3:43 PM
BRISTOL MYERS SQUIBB CO (Filed by)
Celgene (Subject)
Form 425
01/30/2019
3:17 PM
Celgene (Subject)
Form 425
01/30/2019
3:05 PM
Alles Mark J (Reporting)
Celgene (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2019
4:25 PM
BRISTOL MYERS SQUIBB CO (Filed by)
Celgene (Subject)
Form 425
01/28/2019
3:01 PM
Celgene (Subject)
Form 425
01/25/2019
3:30 PM
Celgene (Filer)
Form 8-K/A
01/24/2019
4:00 PM
BRISTOL MYERS SQUIBB CO (Filed by)
Celgene (Subject)
Form 425
01/23/2019
4:00 PM
Celgene (Subject)
Form 425
01/22/2019
4:00 PM
ACCELERON PHARMA INC (Subject)
Celgene (Filed by)
Form SC 13D/A
01/22/2019
4:00 PM
ACCELERON PHARMA INC (Issuer)
Celgene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2019
3:35 PM
BRISTOL MYERS SQUIBB CO (Filed by)
Celgene (Subject)
Form 425
01/17/2019
4:00 PM
BRISTOL MYERS SQUIBB CO (Filed by)
Celgene (Subject)
Form 425
This page was last updated on 11/14/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel